Stryker
Stryker
SYK
NYSE
360.42
USD
-5.73%
About
Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.
It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It also specializes in soft tissue fixation products..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 1.1M |
| Three Month Average Volume | 25.7M |
| High Low | |
| Fifty-Two Week High | 361.41 USD |
| Fifty-Two Week Low | 249.98 USD |
| Fifty-Two Week High Date | 11 Mar 2024 |
| Fifty-Two Week Low Date | 13 Oct 2023 |
| Price and Volume | |
| Current Price | 360.42 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 2.90% |
| Thirteen Week Relative Price Change | -1.27% |
| Twenty-Six Week Relative Price Change | -7.20% |
| Fifty-Two Week Relative Price Change | 1.44% |
| Year-to-Date Relative Price Change | 1.64% |
| Price Change | |
| One Day Price Change | 0.70% |
| Thirteen Week Price Change | 5.67% |
| Twenty-Six Week Price Change | 2.04% |
| Five Day Price Change | 2.02% |
| Fifty-Two Week Price Change | 27.11% |
| Year-to-Date Price Change | 20.36% |
| Month-to-Date Price Change | 10.07% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 48.91607 USD |
| Book Value Per Share (Most Recent Quarter) | 51.85516 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | -3.27019 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | -0.02362 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 14.74711 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 53.42194 USD |
| Revenue Per Share (Trailing Twelve Months) | 55.62086 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 3.05 USD |
| Dividend Per Share (Trailing Twelve Months) | 3.15 USD |
| Dividend Per Share (5 Year) | 2.696 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 8.24863 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 8.96782 USD |
| Normalized (Last Fiscal Year) | 9.38754 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 8.33772 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 9.06755 USD |
| Including Extraordinary Items (Last Fiscal Year) | 8.24863 USD |
| Including Extraordinary Items (Trailing Twelve Months) | 8.96782 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 8.0321 USD |
| Cash Per Share (Most Recent Quarter) | 5.13514 USD |
| Cash Flow Per Share (Last Fiscal Year) | 10.92781 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 11.64478 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 4.22312 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 9 |
| Cash Flow Revenue (Trailing Twelve Months) | 8 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 18.78% |
| Pretax Margin (Last Fiscal Year) | 17.92% |
| Pretax Margin (5 Year) | 15.42% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 63.90% |
| Gross Margin (Trailing Twelve Months) | 64.05% |
| Gross Margin (5 Year) | 63.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 18.97% |
| Operating Margin (Trailing Twelve Months) | 19.69% |
| Operating Margin (5 Year) | 16.71% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 15.44% |
| Net Profit Margin (Trailing Twelve Months) | 16.12% |
| Net Profit Margin (5 Year) | 13.13% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 9.32% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 8.39% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 8.53% |
| Revenue Growth (3 Year) | 8.55% |
| Revenue Change (Trailing Twelve Months) | 9.94% |
| Revenue Per Share Growth | 8.36% |
| Revenue Growth (5 Year) | 12.62% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 0.10% |
| Total Debt (5 Year) | 5.68% |
| Dividends | |
| Dividend Growth (3 Year) | 1.35% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 11.35% |
| EPS Change (Trailing Twelve Months) | 26.71% |
| EPS Growth (3 Year) | 9.49% |
| EPS Growth (5 Year) | 25.19% |
| EBITDA | |
| EBITDA (5 Year) | 7.32% |
| EBITDA (5 Year Interim) | 7.69% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | 1.04% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 69 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 85 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 10.3B |
| Net Debt (Last Fiscal Year) | 9.9B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 7 |
| Price to Sales (Trailing Twelve Months) | 6 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 40 |
| PE Normalized (Last Fiscal Year) | 38 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 38 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 66 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 29 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 40 |
| Dividends | |
| Dividend Yield (5 Year) | 1.06% |
| Dividend Yield | 0.89% |
| Current Dividend Yield | 0.87% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 7 |
| Price to Book (Most Recent Quarter) | 7 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 59 |
| Long Term Debt to Equity (Most Recent Quarter) | 51 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 36.62% |
| Payout Ratio (Trailing Twelve Months) | 34.80% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 59 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 55 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 2.0B |
| Free Cash Flow (Trailing Twelve Months) | 1.6B |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 16 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 70 |
| Total Debt to Equity (Most Recent Quarter) | 62 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 8.24% |
| Return on Assets (Trailing Twelve Months) | 9.01% |
| Return on Assets (5 Year) | 6.60% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 17.98% |
| Return on Equity (Trailing Twelve Months) | 18.58% |
| Return on Equity (5 Year) | 15.44% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 10.12% |
| Return on Investment (Trailing Twelve Months) | 10.94% |
| Return on Investment (5 Year) | 7.84% |